论文部分内容阅读
目的探讨高血压脑出血应用早期降压治疗对血肿扩大的影响。方法将我院110例高血压脑出血患者,随机分为治疗组和对照组两组每组,各55例。治疗组除采用常规治疗外,并服用乌拉地尔控制血压在130～160/90～100mmHg,并持续到入院二十四小时;对照组采用常规治疗;观察比较2组患者入院后24h内血肿扩大情况。结果治疗组血肿扩大发生率为7.3%(4例),对照组为20%(11例)。两组发生率情况差异具有统计学意义,P<0.05。结论高血压脑出血患者早期实施降压治疗,对于防止患者的血肿扩大有着巨大帮助,可有效降低病死和病残几率。
Objective To investigate the effect of early antihypertensive therapy on hematoma enlargement in patients with hypertensive intracerebral hemorrhage. Methods 110 cases of hypertensive intracerebral hemorrhage in our hospital were randomly divided into two groups: treatment group and control group, with 55 cases in each group. In addition to the conventional treatment of the treatment group, and taking urapidil blood pressure control in the 130 ~ 160/90 ~ 100mmHg, and continued until admission 24 hours; control group with conventional treatment; observed two groups of patients within 24 hours after admission hematoma enlargement Happening. Results The incidence of hematoma enlargement was 7.3% (4 cases) in the treatment group and 20% (11 cases) in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion Hypertensive intracerebral hemorrhage in patients with early antihypertensive treatment for the prevention of the expansion of patients with hematoma has a huge help, can effectively reduce the risk of death and morbidity.